Screener
Immucell ICCC Q3 2026 earnings
Reported November 12, 2026 · After market close
Revenue$8.0MBeat by $2.6M
EPS$0.10Beat by $0.05
Revenue estimate$5.4M
EPS estimate$0.05
“We are pleased with our third quarter revenue and with distributor out-the-door volume growth of 18% over 2025. Growth remained broad-based across our sales territories and product lines, supported by an increase in sales activity and continued progress in customer acquisition. We are also encouraged by inventory levels heading into our peak season as we shift our focus to the cow-calf market.”
Next report
Date not yet announcedVersus estimates
Revenue
Q3 2026$8.0MBeat by $2.6M
Q2 2026$7.2MBeat by $1.8MQ1 2026$10.4MBeat by $5.0MQ4 2025$7.6MBeat by $2.2MQ3 2025$5.5MQ2 2025$6.4MDiluted EPS
FAQ
- When did Immucell report Q3 2026 earnings?
- Immucell (ICCC) reported Q3 2026 earnings on November 12, 2026 after market close.
- What were Immucell's Q3 2026 revenue and EPS?
- Immucell reported revenue of $8.0M and eps of $0.10 for Q3 2026.
- Did Immucell beat estimates in Q3 2026?
- Revenue beat the consensus estimate of $5.4M by $2.6M. EPS beat the consensus estimate of $0.05 by $0.05.
- How did Immucell's Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 46.0% from $5.5M a year earlier.
- Where can I find Immucell's Q3 2026 SEC filings?
- You can read the 8-K earnings release (0001437749-26-036629) and the 10-Q periodic report (0001437749-26-036588) directly on SEC EDGAR. The filing index links above go to sec.gov.
